Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Genetic associations at regulatory phenotypes improve fine-mapping of causal variants for 12 immune-mediated diseases

Nature Genetics volume 54, pages 251–262 (2022)Cite this article

Subjects

Abstract

The resolution of causal genetic variants informs understanding of disease biology. We used regulatory quantitative trait loci (QTLs) from the BLUEPRINT, GTEx and eQTLGen projects to fine-map putative causal variants for 12 immune-mediated diseases. We identify 340 unique loci that colocalize with high posterior probability (≥98%) with regulatory QTLs and apply Bayesian frameworks to fine-map associations at each locus. We show that fine-mapping credible sets derived from regulatory QTLs are smaller compared to disease summary statistics. Further, they are enriched for more functionally interpretable candidate causal variants and for putatively causal insertion/deletion (INDEL) polymorphisms. Finally, we use massively parallel reporter assays to evaluate candidate causal variants at the ITGA4 locus associated with inflammatory bowel disease. Overall, our findings suggest that fine-mapping applied to disease-colocalizing regulatory QTLs can enhance the discovery of putative causal disease variants and enhance insights into the underlying causal genes and molecular mechanisms.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Summary diagram of colocalization and fine-mapping results.
Fig. 2: Summary of colocalization results.
Fig. 3: Fine-mapping of IMD and QTL loci.
Fig. 4: Fine-mapping of the ITGA4 locus in monocytes.
Fig. 5: Fine-mapping of the BACH2 locus in CD4+ T cells.

Similar content being viewed by others

Data availability

All the IMD summary statistics were obtained from the GWAS catalog (https://www.ebi.ac.uk/gwas/), Immunobase (https://genetics.opentargets.org/immunobase) and IBD genetics (https://www.ibdgenetics.org/). The BLUEPRINT phase 2 Genotype data (VCFs) have been deposited in the EGA (https://ega-archive.org/datasets/) under accession EGAD00001005192. All QTL summary statistics are available under accession codes EGAD00001005199 and EGAD00001005200. All data are freely available but managed by the BLUEPRINT Data Access Committee. The eQTL data from eQTLGen and GTEx consortium (v7) were obtained from https://www.eqtlgen.org/ and https://www.gtexportal.org, respectively. The independent LD blocks for human genome were obtained from https://bitbucket.org/nygcresearch/ldetect-data. All analysis results are available in the main text or supplementary information. All sequencing reads were mapped to the GRCh37/hg19 (https://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20130301/homo_sapiens/reference/) human reference genome. Source data are provided with this paper.

Code availability

We performed our analyses using the following publicly available software: GATK (v3.4; https://gatk.broadinstitute.org) was used for performing VQSR, BEAGLE (v4.1; https://faculty.washington.edu/browning/beagle/beagle.html) was used for imputation and phasing, VT (v0.5; https://genome.sph.umich.edu/wiki/Vt) was used for variant normalization, LIMIX (v1.0; https://github.com/limix/limix-legacy) was used for QTL analyses, gwas-pw (v0.21; https://github.com/joepickrell/gwas-pw) was used for colocalization, FINEMAP (v1.1; http://www.christianbenner.com/) and CAVIARBF (v0.1.4.1; https://bitbucket.org/Wenan/caviarbf) were used for fine-mapping; GCTA (v1.26.0; https://yanglab.westlake.edu.cn/software/gcta) was used for conditional analysis and TWMR (https://github.com/eleporcu/TWMR/commit/62994ec) was used for Mendelian randomization. All the codes for this study are publicly available at GitHub (https://github.com/teamsoranzo/QTL_IMD_Finemap). PLINK (v1.9; https://www.cog-genomics.org/plink/1.9/) and BCFTools (v1.4; https://samtools.github.io/bcftools) were used for other statistical and data analyses. All codes for this study are publicly available at GitHub (https://github.com/teamsoranzo/QTL_IMD_Finemap).

References

  1. Cooper, G. S., Bynum, M. L. K. & Somers, E. C. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J. Autoimmun. 33, 197–207 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  2. El-Gabalawy, H., Guenther, L. C. & Bernstein, C. N. Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J. Rheumatol. Suppl. 85, 2–10 (2010).

    Article  PubMed  Google Scholar 

  3. Cotsapas, C. et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 7, e1002254 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Visscher, P. M. et al. 10 years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 101, 5–22 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ellinghaus, D. et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat. Genet. 48, 510–518 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. International Genetics of Ankylosing Spondylitis Consortium et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.Nat. Genet. 45, 730–738 (2013).

  7. Huang, H. et al. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature 547, 173–178 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Westra, H.-J. et al. Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes. Nat. Genet. 50, 1366–1374 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Asimit, J. L. et al. Stochastic search and joint fine-mapping increases accuracy and identifies previously unreported associations in immune-mediated diseases. Nat. Commun. 10, 3216 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Spain, S. L. & Barrett, J. C. Strategies for fine-mapping complex traits. Hum. Mol. Genet. 24, R111–R119 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hauberg, M. E. et al. Large-scale identification of common trait and disease variants affecting gene expression. Am. J. Hum. Genet. 100, 885–894 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481–487 (2016).

    Article  CAS  PubMed  Google Scholar 

  13. Fromer, M. et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat. Neurosci. 19, 1442–1453 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Chen, L. et al. Genetic drivers of epigenetic and transcriptional variation in human immune cells. Cell 167, 1398–1414.e1324 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Hannon, E. et al. An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation. Genome Biol. 17, 176 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hernandez, D. G. et al. Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain. Neurobiol. Dis. 47, 20–28 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Emilsson, V. et al. Genetics of gene expression and its effect on disease. Nature 452, 423–428 (2008).

    Article  CAS  PubMed  Google Scholar 

  18. Umans, B. D., Battle, A. & Gilad, Y. Where are the disease-associated eQTLs? Trends Genet. 37, 109–124 (2021).

    Article  CAS  PubMed  Google Scholar 

  19. Chun, S. et al. Limited statistical evidence for shared genetic effects of eQTLs and autoimmune-disease-associated loci in three major immune-cell types. Nat. Genet. 49, 600–605 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Dubois, P. C. A. et al. Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet. 42, 295–302 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43, 1193–1201 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979–986 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. de Lange, K. M. et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat. Genet. 49, 256–261 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  24. Hinks, A. et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat. Genet. 45, 664–669 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. International Multiple Sclerosis Genetics Consortium et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45, 1353–1360 (2013).

  26. International Multiple Sclerosis Genetics Consortium et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214–219 (2011).

  27. Faraco, J. et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet. 9, e1003270 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Cordell, H. J. et al. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat. Commun. 6, 8019 (2015).

    Article  CAS  PubMed  Google Scholar 

  29. Liu, J. Z. et al. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat. Genet. 44, 1137–1141 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Tsoi, L. C. et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44, 1341–1348 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Eyre, S. et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat. Genet. 44, 1336–1340 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376–381 (2014).

    Article  CAS  PubMed  Google Scholar 

  33. Stahl, E. A. et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42, 508–514 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47, 1457–1464 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Onengut-Gumuscu, S. et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 47, 381–386 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Anderson, C. A. et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43, 246–252 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365, eaav7188 (2019).

  39. Cortes, A. & Brown, M. A. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 13, 101 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  40. Polychronakos, C. Fine points in mapping autoimmunity. Nat. Genet. 43, 1173–1174 (2011).

    Article  CAS  PubMed  Google Scholar 

  41. Pickrell, J. K. et al. Detection and interpretation of shared genetic influences on 42 human traits. Nat. Genet. 48, 709–717 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Berisa, T. & Pickrell, J. K. Approximately independent linkage disequilibrium blocks in human populations. Bioinformatics 32, 283–285 (2016).

    CAS  PubMed  Google Scholar 

  43. GTEx Consortium et al. Genetic effects on gene expression across human tissues.Nature 550, 204–213 (2017).

  44. Vosa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53, 1300–1310 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Watt, S. et al. Genetic perturbation of PU.1 binding and chromatin looping at neutrophil enhancers associates with autoimmune disease. Nat. Commun. 12, 2298 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Benner, C. et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493–1501 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Chen, W. et al. Fine mapping causal variants with an approximate Bayesian method using marginal test statistics. Genetics 200, 719–736 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  48. Zhou, J. & Troyanskaya, O. G. Predicting effects of noncoding variants with deep learning-based sequence model. Nat. Methods 12, 931–934 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Caron, B., Luo, Y. & Rausell, A. NCBoost classifies pathogenic non-coding variants in Mendelian diseases through supervised learning on purifying selection signals in humans. Genome Biol. 20, 32 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  50. Ulirsch, J. C. et al. Interrogation of human hematopoiesis at single-cell and single-variant resolution. Nat. Genet. 51, 683–693 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Sandborn, W. J. et al. Vedolizumab as induction and maintenance therapy for Crohn’s disease. N. Engl. J. Med. 369, 711–721 (2013).

    Article  CAS  PubMed  Google Scholar 

  52. Feagan, B. G. et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 369, 699–710 (2013).

    Article  CAS  PubMed  Google Scholar 

  53. Kim-Hellmuth, S. et al. Genetic regulatory effects modified by immune activation contribute to autoimmune disease associations. Nat. Commun. 8, 266 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  54. Fairfax, B. P. et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 343, 1246949 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  55. Javierre, B. M. et al. Lineage-specific genome architecture links enhancers and non-coding disease variants to target gene promoters. Cell 167, 1369–1384.e1319 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Robertson, C. C. et al. Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes. Nat. Genet. 53, 962–971 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Ji, S.-G. et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat. Genet. 49, 269–273 (2017).

    Article  CAS  PubMed  Google Scholar 

  58. Battle, A. et al. Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals. Genome Res. 24, 14–24 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Westra, H.-J. et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238–1243 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Hunter, C. A. & Jones, S. A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16, 448–457 (2015).

    Article  CAS  PubMed  Google Scholar 

  61. Benner, C. et al. Prospects of fine-mapping trait-associated genomic regions by using summary statistics from genome-wide association studies. Am. J. Hum. Genet. 101, 539–551 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Walter, M. et al. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity. Diabetologia 46, 712–720 (2003).

    Article  CAS  PubMed  Google Scholar 

  63. Kindt, A. S. D. et al. Allele-specific methylation of type 1 diabetes susceptibility genes. J. Autoimmun. 89, 63–74 (2018).

    Article  CAS  PubMed  Google Scholar 

  64. Ashuach, T. et al. MPRAnalyze: statistical framework for massively parallel reporter assays. Genome Biol. 20, 183 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  65. Schofield, E. C. et al. CHiCP: a web-based tool for the integrative and interactive visualization of promoter capture Hi-C datasets. Bioinformatics 32, 2511–2513 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Tan, A., Abecasis, G. R. & Kang, H. M. Unified representation of genetic variants. Bioinformatics 31, 2202–2204 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Browning, B. L. & Browning, S. R. Genotype imputation with millions of reference samples. Am. J. Hum. Genet. 98, 116–126 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Browning, S. R. & Browning, B. L. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am. J. Hum. Genet. 81, 1084–1097 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Danecek, P. et al. Twelve years of SAMtools and BCFtools.Gigascience 10, giab008 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  70. Casale, F. P., Rakitsch, B., Lippert, C. & Stegle, O. Efficient set tests for the genetic analysis of correlated traits. Nat. Methods 12, 755–758 (2015).

    Article  CAS  PubMed  Google Scholar 

  71. Stegle, O., Parts, L., Piipari, M., Winn, J. & Durbin, R. Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses. Nat. Protoc. 7, 500–507 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Davis, J. R. et al. An efficient multiple-testing adjustment for eQTL studies that accounts for linkage disequilibrium between variants. Am. J. Hum. Genet. 98, 216–224 (2016).

    Article  CAS  PubMed  Google Scholar 

  73. Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA 100, 9440–9445 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906–913 (2007).

    Article  CAS  PubMed  Google Scholar 

  75. Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369–375 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  79. Muerdter, F. et al. Resolving systematic errors in widely used enhancer activity assays in human cells. Nat. Methods 15, 141–149 (2018).

    Article  CAS  PubMed  Google Scholar 

  80. Klein, J. C. et al. A systematic evaluation of the design and context dependencies of massively parallel reporter assays. Nat. Methods 17, 1083–1091 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Lazic, S. E. Ranking, selecting, and prioritising genes with desirability functions. PeerJ 3, e1444 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  82. Porcu, E. et al. Mendelian randomization integrating GWAS and eQTL data reveals genetic determinants of complex and clinical traits. Nat. Commun. 10, 3300 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

K.K. is supported by the National Institute for Health Research (NIHR) BRC (Biomedical Research Centre, Cardiovascular Theme). This study was conducted using the BLUEPRINT (http://www.blueprint-epigenome.eu/) data funded by EU FP7 High Impact Project BLUEPRINT (HEALTH-F5-2011-282510) and the Canadian Institutes of Health Research (CIHR EP1-120608). N.S. is supported by the Wellcome Trust, the British Heart Foundation, the National Institute for Health Research (NIHR) BRC (Biomedical Research Centre, Cardiovascular Theme) and the Italian Ministry of Finance (to Fondazione Human Technopole). We thank L. Chen and V. Iotchkova for the initial technical discussion on analysis strategy and K. M. de Lange for helping with IBD GWAS data. We thank V. Sankaran and E. Bao for sharing ATAC-seq data. We also thank Q. Lin for releasing the new BLUEPRINT phase 2 data through EGA, European Molecular Biology Laboratory–European Bioinformatics Institute and acknowledge support from the Cambridge National Institute for Health Research Biomedical Research Centre and the International Multiple Sclerosis Genetics Consortium. We also gratefully acknowledge W.H. Ouwehand and K. Downes as part of the National Health Service Blood and Transplant for their contribution to volunteer recruitment and blood collections.

Author information

Authors and Affiliations

  1. Human Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK

    Kousik Kundu, Manuel Tardaguila, Alice L. Mann, Stephen Watt, Hannes Ponstingl, Louella Vasquez, Dominique Von Schiller, Carl A. Anderson, Klaudia Walter & Nicole Soranzo

  2. Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK

    Kousik Kundu & Nicole Soranzo

  3. Division of Respiratory Medicine, Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals, Cambridge, UK

    Nicholas W. Morrell

  4. Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany

    Oliver Stegle

  5. Division of Computational Genomics and Systems Genetics, German Cancer Research Center, Heidelberg, Germany

    Oliver Stegle

  6. Cellular Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK

    Oliver Stegle

  7. Genomic Medicine Center, Children’s Mercy Kansas City and Children’s Mercy Research Institute, Kansas City, MO, USA

    Tomi Pastinen

  8. Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK

    Stephen J. Sawcer

  9. British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK

    Nicole Soranzo

  10. National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK

    Nicole Soranzo

  11. Genomics Research Centre, Human Technopole, Milan, Italy

    Nicole Soranzo

Authors
  1. Kousik Kundu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manuel Tardaguila
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alice L. Mann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stephen Watt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hannes Ponstingl
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Louella Vasquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dominique Von Schiller
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Nicholas W. Morrell
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Oliver Stegle
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Tomi Pastinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Stephen J. Sawcer
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Carl A. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Klaudia Walter
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Nicole Soranzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

K.K. and N.S. designed the study. K.K. and A.L.M. acquired the data. K.K. performed the analysis. M.T. and D.V.S. performed experimental validation. H.P., L.V., N.W.M., O.S., T.P. and S.J.S. provided substantial support on all analyses. K.K., M.T., A.L.M., S.W., C.A.A., K.W. and N.S. interpreted the results. K.K., M.T., A.L.M. and N.S. wrote the manuscript. All authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Nicole Soranzo.

Ethics declarations

Competing interests

C.A.A. is a paid consultant for Genomics plc and BridgeBio. All other authors declare no competing interests.

Peer review

Peer review information

Nature Genetics thanks Constantin Polychronakos and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Supplementary Figures 1–11.

Reporting Summary

Supplementary Table 1

Supplementary Tables 1–12.

Source data

Source Data Fig. 2

Statistical source data.

Source Data Fig. 3

Statistical source data.

Source Data Fig. 4

Statistical source data.

Source Data Fig. 5

Statistical source data.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kundu, K., Tardaguila, M., Mann, A.L. et al. Genetic associations at regulatory phenotypes improve fine-mapping of causal variants for 12 immune-mediated diseases. Nat Genet 54, 251–262 (2022). https://doi.org/10.1038/s41588-022-01025-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41588-022-01025-y

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research